4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzonitrile, 98%, 250mg

1-isobutyl-1H-pyrazol-3-amine, 95%, 100mg

(S)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride, 95.0%, 1g

2-(4-Isobutylphenyl)propanoic acid, 99.00%, 5g

dimethyl (4-fluorobenzyl)phosphonate, 25g

(2-Chloro-6-(trifluoromethyl)pyridin-3-yl)boronic acid, 95.0%, 1g

Ethyl 6-bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate, 95.0%, 1g

6-Hydroxy-chroman-4-one, 95.0%, 100mg

Irinotecan, Hydrochloride Salt, 98.0%, 250mg

Sel de sodium de l'acide gluconique, min 99 %, pour la synthèse, 100 g, emballage plastique.

(1Z,2Z)-Cyclohexane-1,2-dione dioxime, 97.0%, 100g

6-Bromo-4-chloro-thieno[3,2-d]pyrimidine, 95.0%, 10g

N,N'-Bis(4-formylphenyl)-N,N'-diphenylbenzidine>98.0%(N)200mg